Zobrazeno 1 - 10
of 47
pro vyhledávání: '"EL Toverud"'
Publikováno v:
British Journal of Clinical Pharmacology. 12:771-777
1 The metabolism of antipyrine to its three main oxidative metabolites, 4-hydroxyantipyrine, 3-hydroxymethylantipyrine and norphenazone was investigated in vivo and in vitro in separate groups of subjects with normal hepatic function and in the same
Autor:
Alan R. Boobis, Donald S. Davies, EL Toverud, P. N. Bennett, V. Whitmarsh, Stephen Murray, M. J. Brodie
Publikováno v:
European Journal of Clinical Pharmacology. 21:155-160
Antipyrine is oxidised to three main metabolites in man. There is evidence that the different metabolites are products of different forms of cytochrome P-450. The effect of rifampicin administration for two weeks on the rates of formation of these me
Autor:
Alan R. Boobis, Colin T. Dollery, R Harrison, MJ Brodie, EL Toverud, S Webster, W Ellis, Stephen Murray
Publikováno v:
British Journal of Clinical Pharmacology. 9:523-525
Autor:
JC Mucklow, MJ Brodie, CJ Hillyard, BK Park, EL Toverud, Donald S. Davies, I Macintyre, HS Fraser, Colin T. Dollery, PF Wilmana
Publikováno v:
British journal of clinical pharmacology. 8(6)
1 Twenty-four Asian vegetarians had significantly lower 25-hydroxyvitamin D (25-OHD) levels and longer antipyrine half-lives than twenty white non-vegetarians (P less than 0.001). 2 Treatment with oral antipyrine over 4 or 5 weeks in seven vegetarian
Publikováno v:
British journal of clinical pharmacology. 20(1)
Phenacetin O-deethylase activity was impaired, both in vivo and in vitro, in poor metabolisers of debrisoquine, consistent with the work of others. No impairment was observed in the oxidation of acetanilide, amylobarbitone or antipyrine in the PM phe
Publikováno v:
British Journal of Clinical Pharmacology. 7:415P-416P
Autor:
Abuelmagd W; Department of Social Pharmacy, School of Pharmacy, University of Oslo , Oslo , Norway., Osman BB; Department of Social Pharmacy, School of Pharmacy, University of Oslo , Oslo , Norway., Håkonsen H; Department of Social Pharmacy, School of Pharmacy, University of Oslo , Oslo , Norway., Jenum AK; General Practice Research Unit (AFE), Department of General Practice, Institute of Health and Society, University of Oslo , Oslo , Norway., Toverud EL; Department of Social Pharmacy, School of Pharmacy, University of Oslo , Oslo , Norway.
Publikováno v:
Scandinavian journal of primary health care [Scand J Prim Health Care] 2019 Sep; Vol. 37 (3), pp. 345-352. Date of Electronic Publication: 2019 Jul 12.
Autor:
Abuelmagd W; Department of Social Pharmacy, School of Pharmacy, University of Oslo, Oslo, Norway. Electronic address: walaa.abuelmagd@farmasi.uio.no., Afandi B; Diabetes Centre, Tawam-John Hopkins Hospital, Al-Ain, United Arab Emirates. Electronic address: bafandi@seha.ae., Håkonsen H; Department of Social Pharmacy, School of Pharmacy, University of Oslo, Oslo, Norway. Electronic address: helle.hakonsen@farmasi.uio.no., Khmidi S; Diabetes Centre, Tawam-John Hopkins Hospital, Al-Ain, United Arab Emirates. Electronic address: skhamdi@seha.ae., Toverud EL; Department of Social Pharmacy, School of Pharmacy, University of Oslo, Oslo, Norway. Electronic address: e.l.toverud@farmasi.uio.no.
Publikováno v:
Diabetes research and clinical practice [Diabetes Res Clin Pract] 2018 Aug; Vol. 142, pp. 56-62. Date of Electronic Publication: 2018 Apr 16.
Autor:
Abuelmagd W; Department of Social Pharmacy, School of Pharmacy, University of Oslo, Blindern, P.O. Box 1068, 0316, Oslo, Norway. walaa.abuelmagd@farmasi.uio.no., Håkonsen H; Department of Social Pharmacy, School of Pharmacy, University of Oslo, Blindern, P.O. Box 1068, 0316, Oslo, Norway., Mahmood KQ; Department of Social Pharmacy, School of Pharmacy, University of Oslo, Blindern, P.O. Box 1068, 0316, Oslo, Norway., Taghizadeh N; Department of Social Pharmacy, School of Pharmacy, University of Oslo, Blindern, P.O. Box 1068, 0316, Oslo, Norway., Toverud EL; Department of Social Pharmacy, School of Pharmacy, University of Oslo, Blindern, P.O. Box 1068, 0316, Oslo, Norway.
Publikováno v:
Journal of immigrant and minority health [J Immigr Minor Health] 2018 Aug; Vol. 20 (4), pp. 848-853.
Autor:
Gutema G; Department of Social Pharmacy, School of Pharmacy, University of Oslo, P.O. Box 1068, 0316, Oslo, Norway., Håkonsen H; Department of Social Pharmacy, School of Pharmacy, University of Oslo, P.O. Box 1068, 0316, Oslo, Norway. helle.hakonsen@farmasi.uio.no.; Department of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden. helle.hakonsen@farmasi.uio.no., Engidawork E; Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, Addis Ababa University, Addis Ababa, Ethiopia., Toverud EL; Department of Social Pharmacy, School of Pharmacy, University of Oslo, P.O. Box 1068, 0316, Oslo, Norway.
Publikováno v:
BMC health services research [BMC Health Serv Res] 2018 May 03; Vol. 18 (1), pp. 326. Date of Electronic Publication: 2018 May 03.